The template letters below are offered to help with challenging health plan coverage denials of Direct- Acting Antivirals Agents. The letters may be downloaded and modified for submission to health insurers.
Scroll down to access letters for Harvoni (ledipasvir and sofosbuvir), Sovaldi (sofosbuvir) and the Viekira Pak (ombitasvir, paritaprevir and ritonavir tablets co-packaged with dasabuvir tablets).
Acknowledgements: Thank you to Kris Kowdley, MD with Swedish Medical Center for contributing the draft template letters.
Patient Assistance Programs
NASTAD – Information on Patient Assistance Programs for Hepatitis B and C Treatment